Aqtual, Inc.
Maggie Louie is an experienced professional in the field of translational research and scientific consulting. With a background in biochemistry and molecular biology, she has held various leadership roles in both academic and industry settings. Maggie's expertise lies in guiding the development of scientific strategies, building external partnerships with biopharma and academia, and overseeing the translation of innovative platforms into pre-clinical, translational, and clinical studies. She has a proven track record of building and managing research teams, developing long-term partnerships, and advancing oncology diagnostic products through collaboration and diligence of emerging technologies. Through her roles as a professor, principal investigator, and program director, Maggie has a wealth of experience in teaching, research, and program development in biological sciences and chemistry. Her dedication to scientific engagement and collaboration projects with pharmaceutical companies has been instrumental in advancing the field of translational medicine.
This person is not in any teams
Aqtual, Inc.
Aqtual, Inc. is a precision medicine company using its novel cell-free DNA platform to develop products for chronic diseases and oncology. Our mission is to revolutionize the treatment and management of these conditions by bridging the translational gap between groundbreaking research and practical healthcare solutions.